Metraipolis › archive › dc_d0052fc8f01a

Targeting the IL34-CSF1R axis improves metastatic renal cell carcinoma therapy outcome via immune-vascular crosstalk regulation — Europe PMC PMID:40538439

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40538439
DOI
10.1016/j.isci.2025.112752
License (as archived)
solo-consultazione
Archived
2026-10-08T03:53:53.023Z
SHA-256 of the archived text
17b7f5c900d2975ac3d9a6471387fd52fb29796f9c25b3461ed6bf3c268d3913
Stable URL of this page
https://metraipolis.com/documento/dc_d0052fc8f01a

How to cite

Targeting the IL34-CSF1R axis improves metastatic renal cell carcinoma therapy outcome via immune-vascular crosstalk regulation — Europe PMC PMID:40538439 — Europe PMC (en), https://europepmc.org/article/MED/40538439 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d0052fc8f01a (Metraipolis archive dc_d0052fc8f01a, sha256 17b7f5c900d2975ac3d9a6471387fd52fb29796f9c25b3461ed6bf3c268d3913)
BibTeX
@misc{dcd0052fc8f01a,
  title = {Targeting the IL34-CSF1R axis improves metastatic renal cell carcinoma therapy outcome via immune-vascular crosstalk regulation — Europe PMC PMID:40538439},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40538439},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d0052fc8f01a; sha256 17b7f5c900d2975ac3d9a6471387fd52fb29796f9c25b3461ed6bf3c268d3913},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40538439. Agents can read the archived copy with the MCP tool read_document.